Literature DB >> 29287913

Evaluation of ODE-Bn-PMEG, an acyclic nucleoside phosphonate prodrug, as an antiviral against productive HPV infection in 3D organotypic epithelial cultures.

N Sanjib Banerjee1, Hsu-Kun Wang2, James R Beadle3, Karl Y Hostetler3, Louise T Chow2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29287913      PMCID： PMC5800947          DOI： 10.1016/j.antiviral.2017.12.013

Source DB:  PubMed          Journal:  Antiviral Res        ISSN： 0166-3542            Impact factor:   5.970


× No keyword cloud information.
  40 in total

1.  Synthesis and Antiviral Evaluation of Octadecyloxyethyl Benzyl 9-[(2-Phosphonomethoxy)ethyl]guanine (ODE-Bn-PMEG), a Potent Inhibitor of Transient HPV DNA Amplification.

Authors:  James R Beadle; Nadejda Valiaeva; Guang Yang; Jei-Hwa Yu; Thomas R Broker; Kathy A Aldern; Emma A Harden; Kathy A Keith; Mark N Prichard; Tracy Hartman; Robert W Buckheit; Louise T Chow; Karl Y Hostetler
Journal:  J Med Chem       Date:  2016-11-28       Impact factor: 7.446

2.  Casein kinase II phosphorylation of the human papillomavirus-18 E7 protein is critical for promoting S-phase entry.

Authors:  W M Chien; J N Parker; D C Schmidt-Grimminger; T R Broker; L T Chow
Journal:  Cell Growth Differ       Date:  2000-08

3.  Antiviral agent Cidofovir restores p53 function and enhances the radiosensitivity in HPV-associated cancers.

Authors:  Bassam Abdulkarim; Siham Sabri; Eric Deutsch; Heddia Chagraoui; Laurence Maggiorella; Jerome Thierry; François Eschwege; William Vainchenker; Salem Chouaïb; Jean Bourhis
Journal:  Oncogene       Date:  2002-04-04       Impact factor: 9.867

4.  Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis.

Authors:  Laia Bruni; Mireia Diaz; Leslie Barrionuevo-Rosas; Rolando Herrero; Freddie Bray; F Xavier Bosch; Silvia de Sanjosé; Xavier Castellsagué
Journal:  Lancet Glob Health       Date:  2016-07       Impact factor: 26.763

5.  GS-9191 is a novel topical prodrug of the nucleotide analog 9-(2-phosphonylmethoxyethyl)guanine with antiproliferative activity and possible utility in the treatment of human papillomavirus lesions.

Authors:  Grushenka H I Wolfgang; Riri Shibata; Jianying Wang; Adrian S Ray; Sylvia Wu; Edward Doerrfler; Hans Reiser; William A Lee; Gabriel Birkus; Neil D Christensen; Graciela Andrei; Robert Snoeck
Journal:  Antimicrob Agents Chemother       Date:  2009-04-27       Impact factor: 5.191

6.  Epithelial-specific gene expression during differentiation of stratified primary human keratinocyte cultures.

Authors:  J L Wilson; S C Dollard; L T Chow; T R Broker
Journal:  Cell Growth Differ       Date:  1992-08

7.  Robust production and passaging of infectious HPV in squamous epithelium of primary human keratinocytes.

Authors:  Hsu-Kun Wang; Aaron A Duffy; Thomas R Broker; Louise T Chow
Journal:  Genes Dev       Date:  2009-01-08       Impact factor: 11.361

8.  Casein kinase II motif-dependent phosphorylation of human papillomavirus E7 protein promotes p130 degradation and S-phase induction in differentiated human keratinocytes.

Authors:  Nicholas J Genovese; N Sanjib Banerjee; Thomas R Broker; Louise T Chow
Journal:  J Virol       Date:  2008-03-05       Impact factor: 5.103

9.  Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.

Authors:  Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray
Journal:  Int J Cancer       Date:  2014-10-09       Impact factor: 7.396

10.  Cell-free replication of the human papillomavirus DNA with homologous viral E1 and E2 proteins and human cell extracts.

Authors:  S R Kuo; J S Liu; T R Broker; L T Chow
Journal:  J Biol Chem       Date:  1994-09-30       Impact factor: 5.157
View more
  4 in total

1.  Octadecyloxyethyl benzyl tenofovir: A novel tenofovir diester provides sustained intracellular levels of tenofovir diphosphate.

Authors:  James R Beadle; Kathy A Aldern; Xing-Quan Zhang; Nadejda Valiaeva; Karl Y Hostetler; Robert T Schooley
Journal:  Antiviral Res       Date:  2019-09-21       Impact factor: 5.970

2.  Vorinostat, a pan-HDAC inhibitor, abrogates productive HPV-18 DNA amplification.

Authors:  N Sanjib Banerjee; Dianne W Moore; Thomas R Broker; Louise T Chow
Journal:  Proc Natl Acad Sci U S A       Date:  2018-11-01       Impact factor: 11.205

3.  Targeting DNA Damage Response as a Strategy to Treat HPV Infections.

Authors:  N Sanjib Banerjee; Dianne Moore; Cameron J Parker; Thomas R Broker; Louise T Chow
Journal:  Int J Mol Sci       Date:  2019-11-01       Impact factor: 5.923

4.  The First Human Vulvar Intraepithelial Neoplasia Cell Line with Naturally Infected Episomal HPV18 Genome.

Authors:  Ming Wu; Xiu Zhang; Yiyi Kang; Yaqi Zhu; Zhaoyu Su; Jun Liu; Wei Zhang; Hong Chen; Hui Li
Journal:  Viruses       Date:  2022-09-16       Impact factor: 5.818
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.